OmniAb (OABI) Retained Earnings (2021 - 2026)
OmniAb's (OABI) quarterly Retained Earnings came in at -$173.9 million in Q1 2026, down 144.23% year-on-year from $393.1 million in Q1 2025, and down 1449150.0% on a QoQ basis from $12000.0 in Q4 2025.
OmniAb (OABI) Retained Earnings (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Retained Earnings data on file, last reported at -$173.9 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 144.23% year-over-year to -$173.9 million in Q1 2026; TTM through Mar 2026 was -$173.9 million, a 144.23% decrease from a year earlier, with the FY2025 full-year figure at $12000.0, up 100.01% from the prior year.
- Retained Earnings for Q1 2026 stood at -$173.9 million, down from $12000.0 in the prior quarter.
- Over the last five years, Retained Earnings for OABI reached as high as $393.1 million in Q1 2025 and fell as low as -$173.9 million in Q1 2026.
- Historically, Retained Earnings has averaged $36.5 million across 5 years, with a median of -$49000.0 in 2023.
- Across the five-year window, Retained Earnings surged 3932011.11% in 2023 and slumped 180169.39% in 2024, its largest moves.
- Year by year, Retained Earnings stood at $9000.0 in 2022, then jumped by 3932011.11% to $353.9 million in 2023, then sank by 128.65% to -$101.4 million in 2024, then jumped by 100.01% to $12000.0 in 2025, then sank by 1449150.0% to -$173.9 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$173.9 million in Q1 2026, $12000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -173.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -173.89 Mn |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | 393.10 Mn |
| Dec 31, 2024 | -101.40 Mn |
| Sep 30, 2024 | -88.33 Mn |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | -58.33 Mn |
| Dec 31, 2023 | 353.89 Mn |
| Sep 30, 2023 | -49,000.00 |
| Jun 30, 2023 | -49,000.00 |
| Mar 31, 2023 | 335.63 Mn |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | -13.87 Mn |
| Jun 30, 2022 | -14.34 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Sep 30, 2021 | -6.90 Mn |
| Jun 30, 2021 | 24,425.00 |